Supplementary Figure S1 from Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma

Autor: Martin D. McCarter, William A. Robinson, Ross W. McFarland, Rene Gonzalez, Karl D. Lewis, Theresa M. Medina, Eduardo Davila, Dexiang Gao, Kimberly R. Jordan, Kasey L. Couts, Elizabeth Katsnelson, Robert J. Van Gulick, Jessica S.W. Borgers, Dana M. Davis, Victoria M. Cates, Dasha T. Cogswell, Richard P. Tobin
Rok vydání: 2023
Popis: Supplementary figure 1. (A) Changes in other circulating cytokines. Colored box denotes the time when the patients were being treated with ATRA. (B) example gating strategy for CD8+ T cell activation.
Databáze: OpenAIRE